Cargando…
Cardioprotective Properties of the Platelet P2Y(12) Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood
Autores principales: | Bell, R. M., Sivaraman, V., Kunuthur, S. P., Cohen, M. V., Downey, J. M., Yellon, D. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636986/ https://www.ncbi.nlm.nih.gov/pubmed/26179955 http://dx.doi.org/10.1007/s10557-015-6609-2 |
Ejemplares similares
-
Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry
por: Selvarajah, A., et al.
Publicado: (2021) -
The self-reliant entrepreneur
por: Jantsch, John
Publicado: (2019) -
Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry
por: Selvarajah, Abi, et al.
Publicado: (2021) -
Cangrelor Induces More Potent Platelet Inhibition without Increasing Bleeding in Resuscitated Patients
por: Prüller, Florian, et al.
Publicado: (2018) -
Protective CD4(+) Th1 cell-mediated immunity is reliant upon execution of effector function prior to the establishment of the pathogen niche
por: Hohman, Leah S., et al.
Publicado: (2021)